Literature DB >> 18617445

On-column epimerization of dihydroartemisinin: an effective analytical approach to overcome the shortcomings of the International Pharmacopoeia monograph.

Walter Cabri1, Alessia Ciogli, Ilaria D'Acquarica, Michela Di Mattia, Bruno Galletti, Francesco Gasparrini, Fabrizio Giorgi, Silvana Lalli, Marco Pierini, Patrizia Simone.   

Abstract

We developed a cryo-HPLC/UV method for the simultaneous determination of artemisinin (1), alpha-dihydroartemisinin (2alpha), beta-dihydroartemisinin (2beta), and a ubiquitous thermal decomposition product of 2 (designated as diketoaldehyde, 3), starting from the International Pharmacopoeia monograph on dihydroartemisinin. The method takes for the first time the on-column epimerization process of 2 into consideration. Chromatographic separation was obtained under reversed-phase conditions on a Symmetry C18 column (3.5 microm particle size) with a mobile phase consisting of acetonitrile-water 60:40 (v/v), delivered at 0.60-1.00 ml/min flow-rates, with ultraviolet detection at low wavelength (lambda = 210 nm). Low temperatures (T = 0-10 degrees C) were selected on the grounds of a diastereoselective dynamic HPLC (DHPLC) study performed at different temperatures, aimed at identifying the best experimental conditions capable of minimizing the on-column interconversion process.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18617445     DOI: 10.1016/j.jchromb.2008.06.037

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  4 in total

1.  Development and validation of a high-performance liquid chromatography/tandem mass spectrometry method for the determination of artemether and its active metabolite dihydroartemisinin in human plasma.

Authors:  Liusheng Huang; Anura L Jayewardene; Xiaohua Li; Florence Marzan; Patricia S Lizak; Francesca T Aweeka
Journal:  J Pharm Biomed Anal       Date:  2009-07-07       Impact factor: 3.935

2.  Effects of dihydroartemisinin, a metabolite of artemisinin, on colon cancer chemoprevention and adaptive immune regulation.

Authors:  Chong-Zhi Wang; Chunping Wan; Yun Luo; Chun-Feng Zhang; Qi-Hui Zhang; Lina Chen; Zhi Liu; Daniel H Wang; Mallory Lager; Cang-Hai Li; Ting-Liang Jiang; Lifei Hou; Chun-Su Yuan
Journal:  Mol Biol Rep       Date:  2022-01-18       Impact factor: 2.316

3.  A simplified liquid chromatography-mass spectrometry assay for artesunate and dihydroartemisinin, its metabolite, in human plasma.

Authors:  Paktiya Teja-Isavadharm; Duangsuda Siriyanonda; Raveewan Siripokasupkul; Roongnapa Apinan; Nitima Chanarat; Apassorn Lim; Srisombat Wannaying; David Saunders; Mark M Fukuda; Robert S Miller; Peter J Weina; Victor Meléndez
Journal:  Molecules       Date:  2010-12-01       Impact factor: 4.411

Review 4.  Stereodynamic investigation of labile stereogenic centres in dihydroartemisinin.

Authors:  Ilaria D'Acquarica; Francesco Gasparrini; Dorina Kotoni; Marco Pierini; Claudio Villani; Walter Cabri; Michela Di Mattia; Fabrizio Giorgi
Journal:  Molecules       Date:  2010-03-05       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.